(6) Mason C, Xiao L, Duggan C, Imayama I, Foster-Schubert KE, Kong A, Campbell KL, Wang CY, Alfano CM, Blackburn GL, Pollack M, McTiernan A
Cellular Respiration: The Hidden Engine Driving Lifes Energy.
The FDA approved once-daily oral semaglutide (Wegovy) at 25 mg on 22 December 2025, making it the first oral GLP-1 approved specifically for chronic weight management in the US
Continue the small meals approach
In short, while theres still so much that needs sorting out, weve got a breakthrough family of drugs that are already exceeding lofty expectations
Meanwhile, the company is engaged in an ugly fight with Pfizer over its bid to buy obesity drug maker Metsera